ISPOR 2024 Home
Toggle navigation
About
News Center
Award Winners
Program
Program
Learning Formats
Plenary Sessions
Posters
Program Committee
Digital Conference Pass
Exhibits & Sponsorship
Sponsor List
Exhibitor Directory
Media Partners
Photo Gallery
ISPOR
2024
May 5-8, 2024
Home
Events
Past Conferences
ISPOR 2024
Program
Plenary Sessions
Session
Cured and Invisible? Rationale for Mixture-Cure Models As Base-Case for HTA in Diffuse-Large B-Cell Lymphoma (DLBCL)
May 8, 2024, 10:00 AM
«
351
352
353
354
355
356
357
358
359
(current)
360
»